BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang J, Lin M, Li P, Xie J, Lin J, Lu J, Chen Q, Cao L, Lin M, Zheng C, Huang C. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction. European Journal of Surgical Oncology 2017;43:2333-40. [DOI: 10.1016/j.ejso.2017.08.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Lin X, Li Z, Tan C, Ye X, Xiong J, Liu J, Mo A, Shi Y, Qian F, Yu P, Zhao Y. Survival Benefit of Pyloric Lymph Node Dissection for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction Based on Tumor Diameter: A Large Cohort Study. Front Oncol 2021;11:748694. [PMID: 34926257 DOI: 10.3389/fonc.2021.748694] [Reference Citation Analysis]
2 Wu Y, Zhang S, Wang L, Hu X, Zhang Z. Comparative analysis of laparoscopic proximal gastrectomy plus semi-embedded valve anastomosis with laparoscopic total gastrectomy for adenocarcinoma of the esophagogastric junction: a single-center retrospective cohort study. World J Surg Oncol 2021;19:50. [PMID: 33588854 DOI: 10.1186/s12957-021-02163-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Chen X, He F, Chen M, Zhao F. Incidence of lymph node metastasis at each station in Siewert types Ⅱ/Ⅲ adenocarcinoma of the esophagogastric junction: A systematic review and meta-analysis. Surgical Oncology 2020;35:62-70. [DOI: 10.1016/j.suronc.2020.08.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Cai MZ, Lv CB, Cai LS, Chen QX. Priority of lymph node dissection for advanced esophagogastric junction adenocarcinoma with the tumor center located below the esophagogastric junction. Medicine (Baltimore) 2019;98:e18451. [PMID: 31861019 DOI: 10.1097/MD.0000000000018451] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Zhao B, Zhang Z, Mo D, Lu Y, Hu Y, Yu J, Liu H, Li G. Optimal Extent of Transhiatal Gastrectomy and Lymphadenectomy for the Stomach-Predominant Adenocarcinoma of Esophagogastric Junction: Retrospective Single-Institution Study in China. Front Oncol 2018;8:639. [PMID: 30719422 DOI: 10.3389/fonc.2018.00639] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Muro K, Lordick F, Tsushima T, Pentheroudakis G, Baba E, Lu Z, Cho B, Nor I, Ng M, Chen L-, Kato K, Li J, Ryu M-, Zamaniah WIW, Yong W-, Yeh K-, Nakajima T, Shitara K, Kawakami H, Narita Y, Yoshino T, Van Cutsem E, Martinelli E, Smyth E, Arnold D, Minami H, Tabernero J, Douillard J-. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS. Annals of Oncology 2019;30:34-43. [DOI: 10.1093/annonc/mdy498] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]